Twyneo

Twyneo

Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Twyneo for the Treatment of Acne Vulgaris NESS ZIONA, Israel, Dec. 07, 2020 (GLOBE NEWSWIRE) — Sol-Gel…

Read More
pegcetacoplan

pegcetacoplan

pegcetacoplan Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of PNH WALTHAM, Mass., Nov. 16, 2020…

Read More
lisocabtagene maraleucel

lisocabtagene maraleucel

lisocabtagene maraleucel U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol-Myers Squibb’s Biologics License Application (BLA) for Lisocabtagene Maraleucel (liso-cel) for Adult Patients…

Read More